193 related articles for article (PubMed ID: 15828618)
1. [Management of postmenopausal osteoporosis].
Ribot C; Trémollières F; Pouillès JM
Rev Prat; 2005 Feb; 55(4):393-400. PubMed ID: 15828618
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology, etiology, and diagnosis of osteoporosis.
Lane NE
Am J Obstet Gynecol; 2006 Feb; 194(2 Suppl):S3-11. PubMed ID: 16448873
[TBL] [Abstract][Full Text] [Related]
3. Prevention of postmenopausal bone loss and treatment of osteoporosis.
Kleerekoper M
Semin Reprod Med; 2005 May; 23(2):141-8. PubMed ID: 15852199
[TBL] [Abstract][Full Text] [Related]
4. Osteodensitometry in healthy postmenopausal women.
Prescrire Int; 2008 Apr; 17(94):68-72. PubMed ID: 18536138
[TBL] [Abstract][Full Text] [Related]
5. Is treatment of early postmenopausal women with bisphosphonates justified?
Epstein S
Int J Clin Pract; 2007 Jun; 61(6):963-71. PubMed ID: 17504359
[TBL] [Abstract][Full Text] [Related]
6. Recognition of women at risk for fracture and intervention with fast-acting therapies.
Derman R
Int J Fertil Womens Med; 2006; 51(4):183-90. PubMed ID: 17184104
[TBL] [Abstract][Full Text] [Related]
7. Osteoporosis in postmenopausal women. Therapy options across a wide range of risk for fracture.
Miller RG
Geriatrics; 2006 Jan; 61(1):24-30. PubMed ID: 16405361
[TBL] [Abstract][Full Text] [Related]
8. Osteoporosis risk in premenopausal women.
Vondracek SF; Hansen LB; McDermott MT
Pharmacotherapy; 2009 Mar; 29(3):305-17. PubMed ID: 19249949
[TBL] [Abstract][Full Text] [Related]
9. [How to prevent early postmenopausal fracture risk? Proposition of a strategy].
Trémollieres F; Pouilles JM; Ribot C
Gynecol Obstet Fertil; 2009 Jan; 37(1):50-6. PubMed ID: 19110461
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of bisphosphonate therapies for women with postmenopausal osteoporosis: implications of improved persistence with less frequently administered oral bisphosphonates.
Earnshaw SR; Graham CN; Ettinger B; Amonkar MM; Lynch NO; Middelhoven H
Curr Med Res Opin; 2007 Oct; 23(10):2517-29. PubMed ID: 17825128
[TBL] [Abstract][Full Text] [Related]
11. Screening for osteoporosis in the adult U.S. population: ACPM position statement on preventive practice.
Lim LS; Hoeksema LJ; Sherin K;
Am J Prev Med; 2009 Apr; 36(4):366-75. PubMed ID: 19285200
[TBL] [Abstract][Full Text] [Related]
12. Clinical and therapeutic aspects of osteoporosis.
Compston J
Eur J Radiol; 2009 Sep; 71(3):388-91. PubMed ID: 19660883
[TBL] [Abstract][Full Text] [Related]
13. [Absolute risk for fracture and WHO guideline. Fracture risk assessments recommended by World Health Organization and Japanese guidelines for prevention and treatment of osteoporosis 2006].
Nakamura T;
Clin Calcium; 2007 Jul; 17(7):1022-8. PubMed ID: 17607068
[TBL] [Abstract][Full Text] [Related]
14. Prevention, diagnosis, and management of osteoporosis-related fracture: a multifactoral osteopathic approach.
Gronholz MJ
J Am Osteopath Assoc; 2008 Oct; 108(10):575-85. PubMed ID: 18948641
[TBL] [Abstract][Full Text] [Related]
15. Prevention, screening, and management of osteoporosis: an overview of the current strategies.
Bonura F
Postgrad Med; 2009 Jul; 121(4):5-17. PubMed ID: 19641263
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for clinical fractures among postmenopausal women: a 10-year prospective study.
van Geel TA; Geusens PP; Nagtzaam IF; van der Voort DJ; Schreurs CM; Rinkens PE; Dinant GJ
Menopause Int; 2007 Sep; 13(3):110-5. PubMed ID: 17785036
[TBL] [Abstract][Full Text] [Related]
17. Bazedoxifene reduces vertebral and clinical fractures in postmenopausal women at high risk assessed with FRAX.
Kanis JA; Johansson H; Oden A; McCloskey EV
Bone; 2009 Jun; 44(6):1049-54. PubMed ID: 19254788
[TBL] [Abstract][Full Text] [Related]
18. Do current management strategies and guidelines adequately address fracture risk?
McClung MR
Bone; 2006 Feb; 38(2 Suppl 2):S13-7. PubMed ID: 16403495
[TBL] [Abstract][Full Text] [Related]
19. Assessing fracture risk and effects of osteoporosis drugs: bone mineral density and beyond.
Davison KS; Kendler DL; Ammann P; Bauer DC; Dempster DW; Dian L; Hanley DA; Harris ST; McClung MR; Olszynski WP; Yuen CK
Am J Med; 2009 Nov; 122(11):992-7. PubMed ID: 19854322
[TBL] [Abstract][Full Text] [Related]
20. Population-based study of the effectiveness of bone-specific drugs in reducing the risk of osteoporotic fracture.
Perreault S; Dragomir A; Blais L; Moride Y; Rossignol M; Ste-Marie LG; Fernandès JC
Pharmacoepidemiol Drug Saf; 2008 Mar; 17(3):248-59. PubMed ID: 18213734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
